General Synthesis Report of the Different ADS Design Status. Establishment of a Catalogue of the R&D needs

This document is a General Synthesis Report of the Different ADS Design Status being designed within the EUROTRANS Integrated Project; an FP6 European commission partially funded programme. This project had the goal to demonstrate the possibility of nuclear waste transmutation/burning in Accelerator Driven Systems (ADS) at industrial scale.The focus is on a Pb-cooled ADS for the European Facility on Industrial scale Transmuter (ETD/EFIT) with a back-up solution based on an He cooled ADS.As an intermediate step towards this industrial-scale prototype, an eXperimental Transmuter based on ADS concept (ETD/XT-ADS) able to demonstrate both the feasibility of the ADS concept and to accumulate experience when using dedicated fuel sub-assemblies or dedicated pins within a MOX fuel core has been also studied.The two machines (XT-ADS and Pb cooled EFIT) have been designed in a consistent way bringing more credibility to the potential licensing of these plants and with sufficient details to allow definition of the critical issues as regards design, safety and associated technological and basic R&D needs. The different designs fit rather well with the technical objectives fixed at the beginning of the project in consistency with the European Roadmap on ADS development.For what concerns the accelerator, the superconducting LINAC has been clearly assessed as the most suitable concept for the three reactors in particular with respect to the stringent requirements on reliability. Associated R&D needs have been identified and will be focused on critical components (injector, cryomodule) long term testing.The design of the different ADS has been performed in view of what is reasonably achievable pending the completion of R&D programmes. The way the EUROTRANS Integrated Project has been organised with other domains than the DM1 Design being specifically devoted to R&D tasks in support to the overall ETD/EFIT and ETD/XT-ADS design tasks has been helpful. The other domains were centred on the assessment of reactivity measurement techniques (DM2 ECATS), on the development of U-free dedicated fuels (DM3 AFTRA), on materials behaviour and heavy liquid metal technology (DM4 DEMETRA) and on nuclear data assessment (DM5 NUDATRA). Pending questions associated to technology gaps have been identified through the different appropriate R&D work programmes and a Catalogue of the R&D needs has been established.Finally, the work within the EUROTRANS integrated project has provided an overall assessment of the feasibility at a reasonable cost for an ADS based transmutation so that a decision can be taken to launch a detailed design and construction of the intermediate step Experimental ADS now already launched within the 7th FP programme under the name of Common Design Team (CDT)

Cerebellar Transcranial Direct Current Stimulation (ctDCS) Ameliorates Phantom Limb Pain and Non-painful Phantom Limb Sensations

Phantom limb pain (PLP) is a disabling and intractable sensation arising in about 80% of patients after amputation. The aim of this study was to evaluate the possibility to modulate nociceptive processing and pain perception with cerebellar transcranial direct current stimulation (ctDCS) in patients suffering from painful and non-painful phantom limb sensations. Fourteen upper limb amputees underwent ctDCS (anodal or sham, 2.0\ua0mA, 20\ua0min per day, 5\ua0days a week). Clinical scores and electrophysiological parameters were assessed before tDCS, at the end of the 5-day treatment, 2 and 4\ua0weeks later. Laser-evoked potentials (LEPs) were obtained from the stump using a Nd:YAP laser by pulses with short duration (5\ua0ms) and small diameter spots (5\ua0mm). Changes in visual analogue scores (VAS) were evaluated (chronic pain, paroxysmal pain, stump pain, phantom movements, phantom sensations). Anodal polarization significantly dampened LEP amplitudes (N1, p\u2009=\u20090.021 and N2/P2, p\u2009=\u20090.0034), whereas sham intervention left them unchanged. Anodal ctDCS significantly reduced paroxysmal pain (p\u2009<\u20090.0001), non-painful phantom limb sensations (p\u2009<\u20090.0001) and phantom limb movements (p\u2009=\u20090.0003), whereas phantom limb and stump pain did not change compared to the sham condition. Anodal ctDCS significantly improves both paroxysmal pain and non-painful phantom limb sensations, which are likely induced by maladaptive changes in the sensorimotor network and posterior parietal cortex respectively

Design and Supporting R&D of the XT-ADS Spallation Target

International audienceThe XT-ADS is an experimental accelerator-driven system (ADS) that is being developed within the framework of the European FP6 EUROTRANS project that runs from 2005 to 2009. In this paper the current level of the design of the XT-ADS spallation target and the status of corresponding R&D topics with respect to LBE handling, thermal-hydraulics and spallation product confinement are discussed

Design and Supporting R&D of the XT-ADS Spallation Target

International audienceThe XT-ADS is an experimental accelerator-driven system (ADS) that is being developed within the framework of the European FP6 EUROTRANS project that runs from 2005 to 2009. In this paper the current level of the design of the XT-ADS spallation target and the status of corresponding R&D topics with respect to LBE handling, thermal-hydraulics and spallation product confinement are discussed

Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women

Bone mineral density (BMD), the major determinant of osteoporotic fracture risk, has a strong genetic component. The discovery that inactivation of estrogen receptor alpha (ERalpha) gene is associated with low BMD indicated ERalpha as a candidate gene for osteoporosis. We have investigated the role of three ERalpha gene polymorphisms [intron 1 PVU:II and XBA:I RFLPs and TA dinucleotide repeat polymorphism 5' upstream of exon 1] in 610 postmenopausal women. There was a strong linkage disequilibrium between intron 1 polymorphic sites and also between these sites and the microsatellite (TA)(n) dinucleotide polymorphism, with a high degree of coincidence of the short TA alleles and the presence of PVU:II and XBA:I restriction sites. No significant relationship between intron 1 RFLPs and BMD was observed. A statistically significant correlation between (TA)(n) repeat allelic variants and lumbar BMD was observed (P = 0.04, ANCOVA), with subjects with a low number of repeats (TA < 15) showing the lowest BMD values. We observed a statistically significant difference in the mean +/- SD number of TA repeats between analyzed women with a vertebral fracture (n = 73) and the non-fracture group, equivalent to 2.9 (95% CI 1.56-5.72) increased fracture risk in women with a low number of repeats (TA < 15). We conclude that in this large population sample the (TA)(n) dinucleotide repeat polymorphism at the 5' end of the ERalpha gene accounts for part of the heritable component of BMD and might prove useful in the prediction of vertebral fracture risk in postmenopausal osteoporosi